Shah Metacorp Rights Issue 2026: ₹49.80 Cr, Dates Set
Shah Metacorp Ltd
SHAH
Ask AI
Key terms approved by the board
Shah Metacorp Limited has approved the key terms of its proposed rights issue, including the issue price, record date, and the subscription window. The company has set the rights issue price at ₹4.86 per share, including a premium of ₹3.86. The record date has been fixed as May 27, 2026, which will determine shareholder eligibility for the offer. The issue aims to raise up to ₹49.80 crore, subject to full subscription.
Fundraise size and number of shares
The board approved the issuance of 102,469,136 fully paid-up equity shares under the rights issue. Based on the disclosed cap, the company has indicated that the total fund-raising amount will not exceed ₹49.80 crore. The company has described the amount as a maximum, and it is linked to subscription levels in the issue.
Rights entitlement ratio: 36 shares for every 311 held
Shah Metacorp has finalised the rights entitlement ratio at 36 Rights Equity Shares for every 311 fully paid-up equity shares held by eligible shareholders as on the record date. This ratio will apply to shareholders whose names appear on the company’s register of members or beneficial owners as of May 27, 2026. The entitlement ratio is one of the core elements that shareholders use to understand how many rights shares they can apply for.
Issue schedule: opening, closing, and renunciation period
The rights issue is scheduled to open on Thursday, June 11, 2026, and close on Wednesday, June 24, 2026. The company has also disclosed an on-market renunciation period from June 11 to June 22, 2026. This period is relevant for eligible shareholders who intend to renounce their rights entitlement through the market mechanism.
Rights entitlement ISIN disclosed
Shah Metacorp has disclosed the ISIN for the rights entitlement as INE482J20021. This identifier is used for tracking and settlement of rights entitlements in the depository system.
Summary of disclosed rights issue terms
What the company had said earlier about the rights issue
The decision to pursue capital infusion via a rights issue had been approved earlier by the board on December 29, 2025, with an upper size of ₹49.80 crore. At that stage, the company indicated that specific terms such as the issue price, entitlement ratio, record date, and timing would be determined and disclosed later. The more recent disclosures now provide those terms and a fixed schedule.
Exchange approvals: in-principle nod from BSE and NSE
Shah Metacorp stated that it received in-principle approval from the BSE and NSE for the planned rights issue, with the announcement dated May 14, 2026. The company also noted that this approval is a preliminary step and is subject to meeting listing, statutory, and regulatory conditions. After in-principle approvals, the rights issue process typically moves into the stage where final terms, timelines, and operational steps are set and communicated.
Corporate development: resignation of secretarial auditor
Separately, Shah Metacorp disclosed that M/s K Jatin & Co. resigned as Secretarial Auditor effective May 20, 2026. The stated reason was an inability to commit the required time.
Other recent capital-related actions referenced by the company
In earlier updates around the rights issue process, the company referenced other capital actions and corporate steps. These included a rights issue process of about ₹50 crore, an increase in authorised capital to ₹130 crores, and strategic acquisitions completed through share swap arrangements. Shah Metacorp also disclosed that it secured trading approval from BSE and NSE for a preferential allotment of 25.58 crore equity shares priced at ₹4.71 each, and that these shares began trading on December 30, 2025, following approval letters dated December 29, 2025.
Timeline of key dates disclosed
Market impact and why the details matter
A rights issue is a structured way for a listed company to raise funds from existing shareholders based on a record date and a fixed entitlement ratio. For investors, the disclosed price, ratio, and timeline are the practical details that determine eligibility and the decision window. In Shah Metacorp’s case, the company has tied the offer to a maximum fund-raise of ₹49.80 crore through 102,469,136 shares at ₹4.86 per share, subject to subscription.
What to watch next
With the record date and issue dates now disclosed, the next operational milestones typically revolve around the rights entitlement process and the issue period itself. Shah Metacorp has already disclosed the rights entitlement ISIN and the on-market renunciation period dates. Any further updates, if issued, would be expected through the company’s stock exchange disclosures within the announced schedule.
Frequently Asked Questions
Did your stocks survive the war?
See what broke. See what stood.
Live Q4 Earnings Tracker